Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03203239
NA

Red Light Treatment in Peripheral Artery Disease

Sponsor: University of Alabama at Birmingham

View on ClinicalTrials.gov

Summary

Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (\<.9 or \>1.1) will undergo a single 5 min exposure of 670 nm light, 1 cm above the gastrocnemius muscle. Blood flow will be measured by infusion of ultrasound contrast and subsequent acquisition of ultrasound images. 2 blood samples will be collected for measurement of nitric oxide metabolites.

Official title: Vasodilatory Effects of Light on Peripheral Artery Disease

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2018-01-17

Completion Date

2027-12-31

Last Updated

2025-04-01

Healthy Volunteers

No

Interventions

DEVICE

Red Light (670 nm energy)

Light Emitting Diode light source (670 nm wavelength with output up to 75mW/cm2) will be placed over the gastrocnemius muscle. The light will be on for 5 minutes.

DRUG

Octafluoropropane

All subjects will undergo infusion of octafluoropropane to measure peripheral blood flow.

Locations (1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States